Non-Surgical Reversal of Severe Knee Osteoarthritis Using Homoeopathic Management: Case Report

Abstract

Osteoarthritis (OA) of the knee is a progressive degenerative joint disorder characterised by pain, swelling, stiffness, and functional limitation.

 Conventional management includes NSAIDs, physiotherapy, and eventually surgical intervention such as total knee replacement. 

This case study demonstrates a significant non-surgical recovery in a patient diagnosed with severe left knee OA through individualised homoeopathic treatment, avoiding the need for surgery.

Background: Advanced knee osteoarthritis (OA) is often managed surgically when conservative measures fail. 

This case documents substantial symptomatic and radiological improvement in a patient with severe left-knee OA treated with individualised homoeopathic prescriptions, close follow-up and supportive measures.

Case: Mr XYZ, standing-work occupation (battery worker), presented on 29 Feb 2024 with one year of progressive left-knee pain and swelling. X-ray (28 Mar 2024) reported severe degenerative changes with mild effusion. 

Initial therapy prioritised organ-specific homoeopathic remedies, SOS high-potency control for flares, and repeated courses over 18+ months.

Introduction

Knee OA causes pain, functional decline and disability. Standard care: analgesics, physiotherapy, lifestyle/work modification, and joint replacement in advanced cases.

Complementary and individualised homoeopathic approaches are used by some clinicians for symptomatic control and tissue support; evidence is largely observational.

This case documents step-by-step management, objective measures, and outcomes over 18+ months for a patient who avoided surgery and showed radiological improvement.

Patient Information

Identifier: Mr XYZ

Sex: Male,

Age - 55

Occupation: Battery worker — prolonged standing (mechanical aggravation)

Presenting complaint: Left knee swelling and pain for ~1 year at first visit. Varicose veins in legs.

First documented visit: 29 February 2024 (time stamps in electronic record).

Key caveat: The patient record contains inconsistent dates; the clinical timeline utilises visit dates and symptom chronology from the records.

Clinical Findings & Baseline Investigations

Clinical exam (summary): Moderate swelling, soft tissue swelling, occasional mild effusion; pain on weight-bearing and walking.

Initial labs recorded in file (approx): ESR 23, RBS 119, Uric acid 5.8, CRP 3, CBG-N.

 
Imaging: 28 March 2024 X-ray: Reported severe OA changes (joint space narrowing, osteophytes documented in the file).

         BEFORE (28march 2024)                                                                                                                        AFTER (14 Sept 2025)

Therapeutic Intervention, Follow-up timeline & outcomes (subjective + objective)

Date	Clinical Findings / Remarks	Prescription Given	Outcome / Improvement
29 Feb 2024	Initial visit — severe left-knee pain, swelling, limited flexion, difficulty standing.	Bryonia 1M (SOS),  Arnica 30 TDS, FP 6X TDS, Calc Fluor 6X BD	Pain reduced within 1 week; swelling mildly improved.
28 Mar 2024	X-ray: Severe OA changes with mild effusion.	Ruta 30 + Symphytum 30 TDS, Calc Phos 6X BD, Arnica 200 BD, Calc Fluor 30 BD, Ledum Q 10 drops BD, Bryonia 1M SOS	≈ 60% better; swelling down; mobility increased.
25 Apr 2024	Walking is easier; residual stiffness mornings.	Same regimen continued.	≈ 90% improvement; no acute flare.
23 May 2024	Occasional discomfort; swelling is subsiding.	Same base regimen; Bryonia 1M SOS kept.	≈ 50% better; stable condition.
21 Jun 2024	Short flare; mild effusion; later settled.	Re-started Ruta 30  Symphytum 30, Arnica 200 BD,  Calc Fluor 30 BD.	Flare controlled within 1 week.
23 Jul 2024	Good walking tolerance; swelling is better.	Maintenance plan continued.	≈ 80% relief sustained.
20 Aug 2024	Minimal pain; no night ache.	Maintenance Rx.	≈ 70% improvement maintained.
17 Sep 2024	No pain; mild tightness on exertion.	Ruta 30 + Symphytum 30 OD, Arnica 200 OD, Calc Fluor 30 OD.	Stable, symptom-free most days.
02 Apr 2025	80% pain relief; swelling is better.	Maintenance continued.	Stable improvement.
28 Apr 2025	Short flare + itching episode.	Ruta 30 + Symphytum 30 TDS, Arnica 200 BD, CP 6X BD, Calc Fluor 30 thrice/week, Bryonia 1M SOS.	Pain subsided; swelling controlled.
14 Sep 2025	X-ray: Moderate OA, mild effusion, no loose bodies. Vit D = 103.	Maintenance Ruta + Symphytum, Arnica 200 weekly.	No pain, radiological improvement confirmed.

Measurements / Indicators of improvement

Pain & function (subjective % improvement recorded on chart): 

50% → 70% → up to 90% during course; final records show no pain.

Radiology: 

Severe OA (Mar 2024) → Moderate OA with mild effusion and no loose bodies (14 Sep 2025).

Flares: 

Managed successfully with PRN Bryonia and temporary intensification of base regimen.

Return to function: 

Marked improvement in walking tolerance and daily activities per sequential notes.

Adverse events

None recorded in the chart. No medication-related adverse effects documented.

Discussion

Treatment rationale: 

Combination of remedies aimed at (a) acute symptomatic control (Arnica, Bryonia), (b) connective tissue/cartilage support (Ruta, Symphytum), and (c) bony/structural homeostasis (Calc. fluorica). Q/LM potencies (Ledum Q) are used for local inflammatory modulation. Repeated individualised prescribing and maintenance dosing were central to the approach.

Plausibility:

 In this observational single-case context, temporal association is strong: early symptom control, maintained improvement, and later objective radiographic improvement. Mechanisms claimed in homoeopathic literature include modulation of local inflammatory processes and stimulation of endogenous repair; however, these remain hypothesis-generating.

Limitations: 

Single case; lack of standardised pain scores (e.g., WOMAC, VAS) at each visit; inconsistent automated demographic fields in the electronic record; potential unrecorded co-interventions (physiotherapy, workplace changes, weight change) that may have contributed. Vitamin D status was high by later recording (VIT-D = 103) — supplementation/biochemical changes may have influenced healing.

Strength: 

Repeated documented follow-ups with both subjective improvement metrics and repeat imaging showing objective change strengthen the plausibility of a meaningful clinical effect.

Outcome: 

Rapid symptomatic relief was recorded (subjective 70–90% improvements across 2024), with intermittent flares managed on the same protocol. On 14 Sep 2025, repeat X-ray showed radiological improvement (from severe → moderate degenerative changes; no loose bodies; mild effusion). The patient reported no pain at the last follow-up and resumed regular function with maintenance therapy.

Conclusion: 

In this single case, individualised homoeopathic management combined with conservative measures correlated with marked clinical improvement and improved radiology. Controlled studies are needed to evaluate reproducibility.

This longitudinal clinical case shows that an individualised, sustained homoeopathic regimen combined with conservative supportive measures correlated with substantial symptomatic relief and radiological improvement in a patient initially documented to have severe left knee OA. While encouraging, results from single cases cannot establish causality; systematic controlled studies are needed to evaluate efficacy and mechanisms.